SILVERARC CAPITAL MANAGEMENT, LLC - TREVI THERAPEUTICS INC ownership

TREVI THERAPEUTICS INC's ticker is TRVI and the CUSIP is 89532M101. A total of 37 filers reported holding TREVI THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 43.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
SILVERARC CAPITAL MANAGEMENT, LLC ownership history of TREVI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,021,765
-4.5%
927,415
+4.7%
0.61%
-6.4%
Q2 2023$2,117,358
+29.2%
885,9240.0%0.66%
-3.2%
Q1 2023$1,638,959
+10.6%
885,924
+15.4%
0.68%
+59.7%
Q4 2022$1,481,528
+2.5%
767,631
-18.3%
0.42%
-13.3%
Q3 2022$1,446,000939,2650.49%
Other shareholders
TREVI THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Omega Fund Management, LLC 1,263,408$2,843,0000.32%
NEA Management Company, LLC 5,940,796$13,367,0000.17%
TPG Group Holdings (SBS) Advisors, Inc. 4,824,883$10,856,0000.08%
WealthTrust Axiom LLC 39,500$88,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 34,600$78,0000.00%
BlackRock Inc. 44,180$99,0000.00%
LPL Financial LLC 10,000$23,0000.00%
Alberta Investment Management Corp 25,000$56,0000.00%
Tower Research Capital LLC (TRC) 4,187$10,0000.00%
Renaissance Technologies 92,600$208,0000.00%
View complete list of TREVI THERAPEUTICS INC shareholders